SYBX: Synlogic Inc Company Profile & Statistics

About

Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and development platform. The company's pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases such as Urea Cycle Disorder and Phenylketonuria. In addition, the company is leveraging the broad potential of its platform to create Synthetic Biotic medicines for the treatment of other diseases, such as liver disease, inflammatory and immune disorders and cancer. It is collaborating with AbbVie to develop Synthetic Biotic-based treatments for inflammatory bowel disease. Synlogic Inc., formerly known as Mirna Therapeutics Inc., is based in Cambridge, Massachusetts.

Info & Links

CEO

Antoine Awad

Headquarters

301 Binney St., Suite 402
Cambridge, MA 02142, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

Synlogic Inc Statistics

Valuation Measures

Market Capitalization²

16.73M

Enterprise Value

-2.66M

Enterprise Value/EBITDA(ttm)

0.05

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.25

Price to Book(mrq)

1.28

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-98768.72%

Return on Equity(ttm)

-207.84%

Return on Invested Capital(ttm)

-269.53%

Return on Assets(ttm)

-114.81%

Income Statement

Revenue(ttm)

2.78M

Revenue Per Share(ttm)

0.24

Gross Profit(ttm)

2.78M

EBITDA(ttm)³

-49.61M

Net Income Available to Common(ttm)

-44.20M

Diluted EPS(ttm)

-4.16

Share Statistics

Beta (5Y Monthly)

0.80

52-Week Change

-43.92%

S&P 500 52-Week Change

25.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

11.70M

Dividend Yield

0.00%

Float⁴

11.34M

% Held by Insiders

3.02%

% Held by Institutions

63.40%

Balance Sheet

Total Cash(mrq)

19.39M

Total Cash Per Share(mrq)

1.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.71%

Quick Ratio(mrq)

2.71%

Book Value Per Share(mrq)

1.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.54

Free Cash Flow(ytd)

-29.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SYBX

Synlogic Inc

Synlogic Inc Profile